Ceigall India Ltd. makes a corporate announcement

On the IPO-prospectus bridge, the Rs 522 crore inflow would raise the order book from approximately Rs 9,470.84 crore to Rs 9,992.84 crore. The prospectus-era book-to-bill ratio was 3.1x as of March 31, 2024 ^[1]. Using FY24 revenue of Rs 3,029.4 crore ^[2] as the denominator, the pro forma ratio would be approximately 3.30x:

• Order book: Rs 9,470.84 crore + Rs 522 crore = Rs 9,992.84 crore
• Derived book-to-bill: Rs 9,992.84 crore / Rs 3,029.4 crore = 3.30x
• Change versus 3.1x prospectus figure: approximately +0.20x, or about 6%

The Rs 522 crore comprises the Rs 225 crore Himachal Pradesh Bulk Drug Park award ^[3] and the separately reported Rs 297 crore order win ^[4].

Important timing caveat: this Rs 9,992.84 crore figure is a historical pro forma calculation, not the company’s latest reported order book. Ceigall reported an order book of Rs 18,568.3 crore as of June 30, 2026 ^[5]. Since the Rs 297 crore order was reported before that date, it should not be added again without a company-provided order-book bridge. The Rs 225 crore Himachal award was announced after June 30; adding only that award would imply a post-quarter order book of approximately Rs 18,793.3 crore, before execution adjustments or subsequent wins.

Thus, the clean comparison is 3.1x to roughly 3.3x on the IPO-era base, while the company’s current backlog is materially larger at about Rs 18,793 crore on a simple post-Himachal pro forma basis.

The Rs 225 crore contract has an 18-month execution period, but neither it nor the unidentified Rs 297 crore contract carries a publicly disclosed project-level EBITDA margin. The appropriate reference point is Ceigall’s stated pure-EPC EBITDA margin benchmark of 12.5–13.0%; the company’s higher 14.5–15.5% aggregate margin target includes irregular other income, royalty and bonus income and should not be treated as the contract margin. ^[6]

Contract timelines and margin framework

The Rs 225 crore award includes civil infrastructure such as formation cutting, internal roads, drains, a bridge and fencing, which is consistent with an EPC/item-rate execution profile, but the award announcement does not disclose an expected EBITDA percentage. ^[8]

Alignment with historical segment profitability

The filings report segment results, not segment EBITDA. The following are therefore derived segment-result margins = segment result / segment revenue, and are only a proxy for comparing project economics.

Interpretation

• The 12.5–13.0% pure-EPC EBITDA benchmark is above the EPC segment-result margins reported in Q1–Q3 FY26, close to the Q1 FY27 level, and below the stronger Q4 FY26 outcome.
• This suggests the benchmark is within Ceigall’s demonstrated EPC profitability range, but it assumes execution closer to the company’s better-performing periods rather than the weaker first three quarters of FY26.
• The annuity segment has historically generated margins around breakeven in the cited periods, so it is not an appropriate comparator for these road and industrial EPC contracts.
• At the consolidated level, EBITDA margin was 14.55% in FY26 and 14.79% in Q1 FY27, but those figures include business mix and non-contract income effects and therefore should not be used as the standalone margin assumption for either contract. ^[5]

Bottom line: use 12.5–13.0% as the relevant pure-EPC margin reference, not 14.5–15.5%. The Rs 225 crore contract’s 18-month timeline is clear; the Rs 297 crore contract’s terms and any project-specific margin remain unverified in the cited disclosures.

The latest wins do not materially diversify Ceigall’s client base; they modestly increase its central-government concentration. The HPSIDC bulk-drug-park award is a state-level win but was already included in the 30 June 2026 order-book schedule. The genuinely incremental Lada–Sarli award is from MoRTH, so it adds central-client exposure and reinforces Ceigall’s existing Arunachal Pradesh/NH-913 concentration.

Value-weighted order-book effect

†Derived from the disclosed project-level balances. The central and state percentages are identified shares, not a fully reported company-wide split, because some EPC projects and non-NHAI/non-state authorities are not separately classified in the extracted schedule.

• HPSIDC: The Rs 225 Crore Una bulk-drug-park award is a state-level client win ^[17]. However, the same HPSIDC project already appears in the June 30 order-book table with a Rs 1,907 million balance value ^[15]. It should therefore not be added again to the latest reported book.
• MoRTH: The new Lada–Sarli NH-913 award is worth Rs 704.70 Crores excluding GST and is being executed through a 74% Ceigall JV ^[13]. On a gross project-value basis, it lifts the identifiable NHAI/MoRTH share by approximately 1.65 pp.
• Incremental-award mix: If both announcements are viewed against an older pre-June baseline, the combined Rs 929.7 Crore of awards is approximately 75.8% central and 24.2% state by gross contract value. That is not the correct bridge to the June 30 book because the HPSIDC award is already embedded in that book.
• Geography: The Himachal Pradesh award adds state-level industrial infrastructure, but the Arunachal award largely deepens an existing regional cluster: the June order book already contained five MoRTH NH-913 packages in Arunachal Pradesh ^[15]. Thus, the wins expand the project footprint but do not substantially reduce geographic concentration.
• Client risk: The central-client dependence rises rather than falls. Using Ceigall’s 74% JV share for Lada–Sarli instead of the gross project value would produce a lower, but still higher, identifiable central share of approximately 55.98%—the difference reflects the order-book treatment of JV value rather than a change in client exposure ^[13].

Implication: The wins improve geographic reach and add one state-government client, but the larger economic addition is another MoRTH road package. The near-term order-book profile therefore remains dominated by public-sector highway authorities, with diversification occurring more through geography and project type than through a meaningful reduction in NHAI/MoRTH concentration.